- Use of Nafamostat Mesilate as an Anticoagulant during Extracorporeal Membrane Oxygenation
-
Han SJ, Kim HS, Kim KI, Whang SM, Hong KS, Lee WK, Lee SH
- KMID: 1094268
- J Korean Med Sci.
- 2011 Jul;26(7):945-950.
- doi: 10.3346/jkms.2011.26.7.945
Although the incidence of bleeding complications during extracorporeal membrane oxygenator (ECMO) support has decreased in various trials, bleeding is still the most fatal complication. We investigated the ideal dosage and... -
- CITED
-
- Close
- SHARE
-
- Close
